Copyright Reports & Markets. All rights reserved.

Global Cancer Supportive Care Medicine Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Cancer Supportive Care Medicine

      • 1.1 Definition of Cancer Supportive Care Medicine
      • 1.2 Cancer Supportive Care Medicine Segment by Type
        • 1.2.1 Global Cancer Supportive Care Medicine Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Antiemetic Drugs
        • 1.2.3 Erythropoietin-Stimulating Agents
        • 1.2.4 Granulocyte-Stimulating Agents
        • 1.2.5 Analgesics
        • 1.2.6 Others
      • 1.3 Cancer Supportive Care Medicine Segment by Applications
        • 1.3.1 Global Cancer Supportive Care Medicine Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Chemotherapy-Induced Anemia
        • 1.3.3 CINV
        • 1.3.4 Bone Metastasis
        • 1.3.5 Cancer Pain
        • 1.3.6 Other
      • 1.4 Global Cancer Supportive Care Medicine Overall Market
        • 1.4.1 Global Cancer Supportive Care Medicine Revenue (2014-2025)
        • 1.4.2 Global Cancer Supportive Care Medicine Production (2014-2025)
        • 1.4.3 North America Cancer Supportive Care Medicine Status and Prospect (2014-2025)
        • 1.4.4 Europe Cancer Supportive Care Medicine Status and Prospect (2014-2025)
        • 1.4.5 China Cancer Supportive Care Medicine Status and Prospect (2014-2025)
        • 1.4.6 Japan Cancer Supportive Care Medicine Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Cancer Supportive Care Medicine Status and Prospect (2014-2025)
        • 1.4.8 India Cancer Supportive Care Medicine Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine
      • 2.3 Manufacturing Process Analysis of Cancer Supportive Care Medicine
      • 2.4 Industry Chain Structure of Cancer Supportive Care Medicine

      3 Development and Manufacturing Plants Analysis of Cancer Supportive Care Medicine

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Cancer Supportive Care Medicine Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Cancer Supportive Care Medicine
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Cancer Supportive Care Medicine Production and Capacity Analysis
      • 4.2 Cancer Supportive Care Medicine Revenue Analysis
      • 4.3 Cancer Supportive Care Medicine Price Analysis
      • 4.4 Market Concentration Degree

      5 Cancer Supportive Care Medicine Regional Market Analysis

      • 5.1 Cancer Supportive Care Medicine Production by Regions
        • 5.1.1 Global Cancer Supportive Care Medicine Production by Regions
        • 5.1.2 Global Cancer Supportive Care Medicine Revenue by Regions
      • 5.2 Cancer Supportive Care Medicine Consumption by Regions
      • 5.3 North America Cancer Supportive Care Medicine Market Analysis
        • 5.3.1 North America Cancer Supportive Care Medicine Production
        • 5.3.2 North America Cancer Supportive Care Medicine Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Cancer Supportive Care Medicine Import and Export
      • 5.4 Europe Cancer Supportive Care Medicine Market Analysis
        • 5.4.1 Europe Cancer Supportive Care Medicine Production
        • 5.4.2 Europe Cancer Supportive Care Medicine Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Cancer Supportive Care Medicine Import and Export
      • 5.5 China Cancer Supportive Care Medicine Market Analysis
        • 5.5.1 China Cancer Supportive Care Medicine Production
        • 5.5.2 China Cancer Supportive Care Medicine Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Cancer Supportive Care Medicine Import and Export
      • 5.6 Japan Cancer Supportive Care Medicine Market Analysis
        • 5.6.1 Japan Cancer Supportive Care Medicine Production
        • 5.6.2 Japan Cancer Supportive Care Medicine Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Cancer Supportive Care Medicine Import and Export
      • 5.7 Southeast Asia Cancer Supportive Care Medicine Market Analysis
        • 5.7.1 Southeast Asia Cancer Supportive Care Medicine Production
        • 5.7.2 Southeast Asia Cancer Supportive Care Medicine Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Cancer Supportive Care Medicine Import and Export
      • 5.8 India Cancer Supportive Care Medicine Market Analysis
        • 5.8.1 India Cancer Supportive Care Medicine Production
        • 5.8.2 India Cancer Supportive Care Medicine Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Cancer Supportive Care Medicine Import and Export

      6 Cancer Supportive Care Medicine Segment Market Analysis (by Type)

      • 6.1 Global Cancer Supportive Care Medicine Production by Type
      • 6.2 Global Cancer Supportive Care Medicine Revenue by Type
      • 6.3 Cancer Supportive Care Medicine Price by Type

      7 Cancer Supportive Care Medicine Segment Market Analysis (by Application)

      • 7.1 Global Cancer Supportive Care Medicine Consumption by Application
      • 7.2 Global Cancer Supportive Care Medicine Consumption Market Share by Application (2014-2019)

      8 Cancer Supportive Care Medicine Major Manufacturers Analysis

      • 8.1 Amgen
        • 8.1.1 Amgen Cancer Supportive Care Medicine Production Sites and Area Served
        • 8.1.2 Amgen Product Introduction, Application and Specification
        • 8.1.3 Amgen Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Helsinn Healthcare
        • 8.2.1 Helsinn Healthcare Cancer Supportive Care Medicine Production Sites and Area Served
        • 8.2.2 Helsinn Healthcare Product Introduction, Application and Specification
        • 8.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Johnson &Johnson
        • 8.3.1 Johnson &Johnson Cancer Supportive Care Medicine Production Sites and Area Served
        • 8.3.2 Johnson &Johnson Product Introduction, Application and Specification
        • 8.3.3 Johnson &Johnson Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Merck
        • 8.4.1 Merck Cancer Supportive Care Medicine Production Sites and Area Served
        • 8.4.2 Merck Product Introduction, Application and Specification
        • 8.4.3 Merck Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 F. Hoffmann-La Roche
        • 8.5.1 F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Sites and Area Served
        • 8.5.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
        • 8.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 GlaxoSmithKline
        • 8.6.1 GlaxoSmithKline Cancer Supportive Care Medicine Production Sites and Area Served
        • 8.6.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Heron Therapeutics
        • 8.7.1 Heron Therapeutics Cancer Supportive Care Medicine Production Sites and Area Served
        • 8.7.2 Heron Therapeutics Product Introduction, Application and Specification
        • 8.7.3 Heron Therapeutics Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Kyowa Hakko Kirin
        • 8.8.1 Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Sites and Area Served
        • 8.8.2 Kyowa Hakko Kirin Product Introduction, Application and Specification
        • 8.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Novartis
        • 8.9.1 Novartis Cancer Supportive Care Medicine Production Sites and Area Served
        • 8.9.2 Novartis Product Introduction, Application and Specification
        • 8.9.3 Novartis Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 TESARO
        • 8.10.1 TESARO Cancer Supportive Care Medicine Production Sites and Area Served
        • 8.10.2 TESARO Product Introduction, Application and Specification
        • 8.10.3 TESARO Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Teva Pharmaceutical Industries

      9 Development Trend of Analysis of Cancer Supportive Care Medicine Market

      • 9.1 Global Cancer Supportive Care Medicine Market Trend Analysis
        • 9.1.1 Global Cancer Supportive Care Medicine Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Cancer Supportive Care Medicine Regional Market Trend
        • 9.2.1 North America Cancer Supportive Care Medicine Forecast 2019-2025
        • 9.2.2 Europe Cancer Supportive Care Medicine Forecast 2019-2025
        • 9.2.3 China Cancer Supportive Care Medicine Forecast 2019-2025
        • 9.2.4 Japan Cancer Supportive Care Medicine Forecast 2019-2025
        • 9.2.5 Southeast Asia Cancer Supportive Care Medicine Forecast 2019-2025
        • 9.2.6 India Cancer Supportive Care Medicine Forecast 2019-2025
      • 9.3 Cancer Supportive Care Medicine Market Trend (Product Type)
      • 9.4 Cancer Supportive Care Medicine Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Cancer Supportive Care Medicine Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Cancer Supportive Care Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Cancer Supportive Care Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Supportive Care Medicine market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Supportive Care Medicine in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Cancer Supportive Care Medicine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Amgen
        Helsinn Healthcare
        Johnson &Johnson
        Merck
        F. Hoffmann-La Roche
        GlaxoSmithKline
        Heron Therapeutics
        Kyowa Hakko Kirin
        Novartis
        TESARO
        Teva Pharmaceutical Industries

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Antiemetic Drugs
        Erythropoietin-Stimulating Agents
        Granulocyte-Stimulating Agents
        Analgesics
        Others

        Segment by Application
        Chemotherapy-Induced Anemia
        CINV
        Bone Metastasis
        Cancer Pain
        Other

        Buy now